Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

The Cannigma

SEPTEMBER 28, 2021

A poll in May 2021 found that nearly 40% of Irish citizens support legalizing cannabis for recreational use, and over 90% support the legalization of medical marijuana. Medical cannabis was started in 2021 under specific conditions in limited products only in Ireland (Shutterstock). However, Irish law does allow the sale of CBD.

Law 97

Law Marijuana Treatment Epilepsy 97

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. The post France Wants to Experiment With Giving Away Free Medical Cannabis in 2021 appeared first on Cannabis Central.

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

The Cannigma

SEPTEMBER 28, 2021

A poll in May 2021 found that nearly 40% of Irish citizens support legalizing cannabis for recreational use, and over 90% support the legalization of medical marijuana. Medical cannabis was started in 2021 under specific conditions in limited products only in Ireland (Shutterstock). However, Irish law does allow the sale of CBD.

Law 96

Law Marijuana Treatment Epilepsy 96

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

MMJ Recs

NOVEMBER 11, 2020

Which countries have been taking steps towards medical marijuana (MMJ) legalization that could potentially be finalized in 2021 or shortly after? This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

TheAnswerPage

AUGUST 7, 2021

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy 61

Epilepsy Topical Treatment CBD 61

Cannabis Law Report

SEPTEMBER 6, 2021

DUBLIN–(BUSINESS WIRE)–The “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. during 2021-2026. Cannabis is safer and has less severe side effects in comparison to other treatment options.

Chronic Pain 66

Chronic Pain Research and Development Clinical Trials Epilepsy 66

The Cannigma

JULY 5, 2022

A 2021 bill expanded legal products to also include transdermal patches, lotions, and capsules, none of which can currently be legally purchased. There were bills introduced during the 2021 and 2022 legislative sessions to reduce the penalties for possession and jumpstart the licensing process, but they did not pass.

Law 119

Law Decriminalization Programs Patients 119

TheAnswerPage

JUNE 19, 2021

The results of recent clinical trials indicate that Cannabidiol (CBD) reduces seizures among patients with refractory epilepsies of various etiologies. A May 2021 study demonstrated that CBD does not lose its efficacy in controlling seizures over a treatment period of up to 60 months. 29 May 2021 [link].

Clinical Trials 40

Clinical Trials Epilepsy Treatment CBD 40

Cannabis Law Report

SEPTEMBER 9, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions. billion by 2028, registering a CAGR of 26.3% Medical Use.

Recreational 73

Recreational Hemp THC Legalization 73

TheAnswerPage

MARCH 30, 2021

Currently, CBD-containing gels are being evaluated for the treatment of Fragile X Syndrome, autism spectrum disorder in pediatric patients, 22q (aka DiGeorge Syndrome), and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See Answer. See Answer.

Epilepsy 11

Epilepsy Topical Treatment Patients 11

Cannabis Law Report

AUGUST 2, 2021

2, 2021 /PRNewswire/ — SciSparc Ltd. OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

MMJ Recs

FEBRUARY 18, 2021

Millions of patients all across the nation are now seeing a massive improvement in their quality of life thanks to MMJ treatment. Medical marijuana is being used in the US to treat a wide variety of illnesses, such as chronic pain, glaucoma, migraine, muscle spasms, insomnia, arthritis, PTSD, and epilepsy. appeared first on MMJRecs.

Legalization 52

Legalization Marijuana Treatment Programs 52

Cannabis Law Report

DECEMBER 23, 2021

Findings in The Pharmaceutical Cannabis Report: 2nd Edition include: The author estimates the market size for the three most widely used cannabinoid pharmaceuticals (Epidiolex, Sativex, Dronabinol) to be worth just under €900 million as of 2021, growing to €1.8 billion by 2025.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

MMJ Recs

AUGUST 25, 2021

Dispensaries have opened up for business all across the state, but which Pennsylvania dispensaries are leading the pack and bringing patients the best service in 2021? Image by StayRegular on Pixabay : What do Pennsylvania dispensaries sell in 2021? How Do You Get A Pennsylvania MMJ Card In 2021? PA Dispensary Prices.

Dispensary 52

Dispensary Conditions Patients Education 52

The Cannigma

JULY 24, 2022

The most recent medical marijuana bill , introduced in 2021, would have created a program, albeit a restrictive one. However, there are only three approved conditions for this oil, and patients must have tried and failed with other traditional treatments before they can be approved. South Carolina medical marijuana program.

Law 137

Law THC Hash Oil 137

Cannabis Law Report

SEPTEMBER 12, 2021

September 09, 2021. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Earlier this year, Gov.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

The Cannigma

SEPTEMBER 13, 2021

In July, 2021, Israeli lawmakers rejected a bill that would have decriminalized recreational marijuana use. The medical cannabis program in Israel is not as lenient as those in many other countries, and patients typically are required to attempt other medical treatments before cannabis is approved.

Legalization 124

Legalization Decriminalization Patients Cannabis 124

TheAnswerPage

FEBRUARY 6, 2021

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? See Answer. See Answer.

Epilepsy 40

Epilepsy Pharmaceutical Treatment Food 40

MMJ Recs

AUGUST 5, 2021

Missouri residents are getting to enjoy hugely improved quality of life thanks to the rejuvenating effects of MMJ treatment. All of Missouri’s MMJ dispensaries sell high-quality, locally grown products – but which MO dispensaries are most popular in 2021? How Do You Get A Missouri MMJ Card In 2021? Flora Farms.

Dispensary 52

Dispensary Chronic Pain Treatment Patients 52

Veriheal

MARCH 1, 2021

Seizures, including those characteristic of epilepsy. Recreational cannabis is legal to purchase in Arizona as of 2021, with a possession limit of up to 2.5 However, until 2021, no states bordering Montana had legalized medical marijuana, making it illegal to bring your own cannabis into the state. Amyotrophic lateral Sclerosis.

Patients 119

Patients Marijuana Concentrates Recreational 119

TheAnswerPage

OCTOBER 11, 2021

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A Review of the Safety and Effectiveness of Select Ingredients in Compounded Topical Pain Creams.” ” National Academies of Sciences, Engineering, and Medicine.

Epilepsy 40

Epilepsy Topical Treatment Safety 40

MedicalJane

OCTOBER 3, 2019

“Because if it helps with epilepsy and it helps in terms of decreasing the spike activity, we might also get improvement in some of the aggression, or the self-injury, or the temper tantrums.” It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. There is no known cure for autism.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

TheAnswerPage

JULY 22, 2021

For example, Epidiolex (a CBD product) has been approved by the US FDA for the treatment of rare pediatric seizure disorders (Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex). e58010716930, 2021. de; SILVA , A. ABREU , L. GONZAGA, R. ; GONZAGA, R. Medicinal uses of Cannabis sp. DOI: 10.3344. See the Answer.

Research and Development 40

Research and Development Epilepsy Treatment Cannabinoids 40

MMJ Recs

DECEMBER 15, 2021

Recreational marijuana became legal in New York on March 31st, 2021. In order to get a New York medical marijuana card, a person must be a resident of New York State or be temporarily residing in the state for the purpose of receiving treatment. It’s not currently possible to use an out-of-state medical marijuana card in New York.

Chronic Pain 98

Chronic Pain Dispensary Recreational Patients 98

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. It is exploring the treatment of pain from osteoarthritis with cannabinoid ratios – specifically, CBD + CBN and CBD + THC versus placebo.

THC 140

THC Clinical Trials Sleep Cannabinoids 140

TheAnswerPage

NOVEMBER 3, 2021

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy 45

Epilepsy Topical Treatment CBD 45

TheAnswerPage

JUNE 2, 2021

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy 45

Epilepsy Topical Treatment CBD 45

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. RADNOR, Pa.–(BUSINESS Data Highlights.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Veriheal

DECEMBER 28, 2021

The report authors noted that THC, on the other hand, is touted as a popular option for alleviating the negative effects of AIDS and cancer treatment. Additionally, oral capsules and solutions constitute a majority of revenue for the market, which is also being fueled by the plant’s adoption as a cancer treatment. Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

TheAnswerPage

JULY 13, 2021

Yes, GW Pharmaceuticals (the makers of Epidiolex) had trialed CBDV in adult epilepsy, but the study did not meet its primary endpoint of seizure reduction. That trial did not continue.

Clinical Trials 45

Clinical Trials Epilepsy Pharmaceutical Treatment 45

Cannabis Law Report

DECEMBER 3, 2021

Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder with Comorbid Lennox-Gastaut Syndrome: A Post-hoc Analysis from the Marigold Study. change in MMSF).

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

TheAnswerPage

JULY 5, 2021

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition? Schlag, A.K., O’Sullivan, S.E,

Epilepsy 40

Epilepsy Cannabinoids Medicine Conditions 40

TheAnswerPage

AUGUST 15, 2021

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy 40

Epilepsy Programs Treatment CBD 40

TheAnswerPage

JUNE 10, 2021

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy 40

Epilepsy Programs Treatment CBD 40